Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Abstract Background Recognizing resistance or susceptibility to the current standard cisplatin and paclitaxel treatment could improve therapeutic outcomes of metastatic or recurrent cervical cancer. Methods Forty-five tissue samples from patients participating in a phase II trial of cisplatin and if...

Full description

Bibliographic Details
Main Authors: Sofia Karageorgopoulou, Ioannis D. Kostakis, Maria Gazouli, Sonia Markaki, Marios Papadimitriou, Evangelos Bournakis, Meletios-Athanassios Dimopoulos, Christos A Papadimitriou
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Cancer
Online Access:http://link.springer.com/article/10.1186/s12885-017-3435-x

Internet

http://link.springer.com/article/10.1186/s12885-017-3435-x

Similar Items